Fundamental Research Division
The DRF at the CEA assemble approximately 6,000 scientists since January 2016.
The DSV has the capacity for methodological and technical innovation based on the quality of its technological platforms and its equipment. This is combined with the expertise of its teams, notably in the fields of imaging, pharmacology, large-scale biology, structural biology, radiotoxicology, and chemistry.
The DSV has a unique collection of imaging instruments for investigating the living, from pathophysiological mechanisms to patient care.
Researchers at the DSV develop methodologies and innovative skills to understand the dynamics and structure of macromolecules within the complexity of the cell.
The DSV combines high throughput screening with its expertise in combinatorial chemistry, functional genomics and cell biology to identify bioactive molecules and validate targets.
Due to its strong positioning in all “omics” approaches, the DSV has mastered high throughput techniques allowing the simultaneous analysis of a large number of variables in genomics, transcriptomics, proteomics, metabolomics and lipidomics.
The DSV has an exceptional range of tools for studying the impact of ionizing radiation on humans and the environment.
At the DSV, chemistry is frequently used to develop tools for basic research in biology, diagnostic innovation, industrial biotechnology and green chemistry.
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.